Skip to main content
Signal8

Kropotova Alexandra

SEC insider (Form 3/4/5 filer). CIK 0001825323. Director at iBio, Inc. (IBIO) and 1 other issuer. 12 reported Form 4/5 transactions since Sep 2024; latest on Oct 14, 2026. Located in SAN DIEGO, CA.

Companies Kropotova Alexandra has filed insider reports for

  • iBio, Inc. (IBIO): Director
  • SAB Biotherapeutics, Inc. (SABS): Officer, CHIEF MEDICAL OFFICER
Kropotova Alexandra profile photo

Kropotova Alexandra

CIK: 0001825323

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (41.7%)

Compensation grants

Other (G, F, J, C, D, …)7 (58.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

iBio, Inc. logo
IBIO

iBio, Inc.

Director
SAB Biotherapeutics, Inc. logo
SABS

SAB Biotherapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

  • iBio, Inc. logo
    IBIO

    iBio, Inc.

    Oct 14, 2026
    Award

    Stock Option (right to buy)

    Direct
    38K shares-
  • SAB Biotherapeutics, Inc. logo
    SABS

    SAB Biotherapeutics, Inc.

    Sep 17, 2026
    Tax Payment
    Direct
    473 shares-
  • SAB Biotherapeutics, Inc. logo
    SABS

    SAB Biotherapeutics, Inc.

    Jun 25, 2026
    Tax Payment
    Direct
    988 shares-
  • SAB Biotherapeutics, Inc. logo
    SABS

    SAB Biotherapeutics, Inc.

    Mar 24, 2026
    Tax Payment
    Direct
    988 shares-
  • SAB Biotherapeutics, Inc. logo
    SABS

    SAB Biotherapeutics, Inc.

    Feb 3, 2026
    Award

    Stock option (right to buy)

    Direct
    2.4M shares-
  • SAB Biotherapeutics, Inc. logo
    SABS

    SAB Biotherapeutics, Inc.

    Dec 11, 2025
    Tax Payment
    Direct
    988 shares-
  • iBio, Inc. logo
    IBIO

    iBio, Inc.

    Nov 20, 2025
    Award

    Stock Option (right to buy)

    Direct
    13.5K shares-
  • SAB Biotherapeutics, Inc. logo
    SABS

    SAB Biotherapeutics, Inc.

    Sep 19, 2025
    Tax Payment
    Direct
    2K shares-
  • SAB Biotherapeutics, Inc. logo
    SABS

    SAB Biotherapeutics, Inc.

    Aug 26, 2025
    Award

    Stock Option (right to buy)

    Direct
    2.4M shares-
  • SAB Biotherapeutics, Inc. logo
    SABS

    SAB Biotherapeutics, Inc.

    Mar 27, 2025
    Tax Payment
    Direct
    1.2K shares-

1-10 of 12